Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DALI study of atorvastatin in type 2 diabetes with hypertriglyceridemia
NL-OMON24407Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jun 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of atorvastatin in type 2 diabetes mellitus (T2DM) and hypertriglyceridemia (3 arms), sponsored by Erasmus MC. Primary endpoint: Reduction in triglyceride levels. Started Jun 1998; status: active, not recruiting.
02
Drugs
atorvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)hypertriglyceridemia
Beyond the preview
Go deeper on NL-OMON24407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24407.